Profiles

Keywords
Last Name
Institution

Steven Bines

Concepts (123)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
5
2017
60
1.470
Why?
Sentinel Lymph Node Biopsy
2
2017
20
0.640
Why?
Aptitude Tests
1
2013
2
0.630
Why?
General Surgery
2
2013
55
0.620
Why?
Genetic Therapy
2
2013
88
0.600
Why?
Ileal Neoplasms
1
2011
2
0.550
Why?
Skin Neoplasms
2
2013
138
0.520
Why?
Clinical Competence
1
2013
244
0.510
Why?
Herpesvirus 1, Human
1
2010
3
0.500
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2010
31
0.490
Why?
Genetic Vectors
1
2010
65
0.490
Why?
Laparoscopy
1
2011
169
0.470
Why?
Rosaniline Dyes
1
2008
3
0.450
Why?
Radioisotopes
1
2008
15
0.450
Why?
Neoplasm Invasiveness
1
2008
96
0.430
Why?
Neoplasm Staging
2
2017
465
0.430
Why?
Breast Neoplasms
1
2008
399
0.320
Why?
Immunotherapy
2
2013
63
0.300
Why?
Cancer Vaccines
2
2012
19
0.270
Why?
Carcinoma, Renal Cell
2
2012
75
0.250
Why?
Opioid-Related Disorders
1
2017
20
0.200
Why?
Watchful Waiting
1
2017
8
0.200
Why?
Lymph Node Excision
1
2017
37
0.200
Why?
Humans
13
2017
26074
0.190
Why?
Clinical Clerkship
2
2013
27
0.190
Why?
Analgesics, Opioid
1
2017
118
0.190
Why?
Pain Management
1
2017
112
0.180
Why?
Retrospective Studies
3
2017
2661
0.180
Why?
Lymph Nodes
2
2017
79
0.180
Why?
Chronic Disease
1
2017
471
0.180
Why?
Gastrostomy
1
2015
10
0.170
Why?
Gastroscopy
1
2015
9
0.170
Why?
Mental Disorders
1
2017
185
0.170
Why?
Patient Safety
1
2015
44
0.160
Why?
Ambulatory Surgical Procedures
1
2015
72
0.160
Why?
Animals, Laboratory
1
2013
3
0.160
Why?
Adult
5
2017
8550
0.160
Why?
Hypopigmentation
1
2013
1
0.150
Why?
Vitiligo
1
2013
2
0.150
Why?
Students, Medical
1
2013
40
0.150
Why?
Head and Neck Neoplasms
1
2015
130
0.150
Why?
Mutant Proteins
1
2013
9
0.150
Why?
HSP70 Heat-Shock Proteins
1
2013
8
0.150
Why?
Education, Medical
1
2013
37
0.150
Why?
Autoimmunity
1
2013
23
0.150
Why?
Animals
6
2013
4855
0.150
Why?
Molecular Targeted Therapy
1
2013
37
0.150
Why?
Immunotherapy, Active
1
2012
4
0.140
Why?
Middle Aged
5
2017
9801
0.140
Why?
Laparoscopes
1
2011
3
0.140
Why?
Biopsy, Needle
1
2011
114
0.130
Why?
Kidney Neoplasms
1
2012
104
0.130
Why?
Defective Viruses
1
2010
1
0.130
Why?
Cytopathogenic Effect, Viral
1
2010
2
0.130
Why?
Injections, Intralesional
1
2010
29
0.120
Why?
Clinical Protocols
1
2010
59
0.120
Why?
Antineoplastic Agents
1
2013
292
0.120
Why?
Immunohistochemistry
1
2011
466
0.120
Why?
Virus Replication
1
2010
88
0.120
Why?
Prospective Studies
2
2013
1544
0.110
Why?
Prostatic Neoplasms
1
2010
131
0.110
Why?
Coloring Agents
1
2008
16
0.110
Why?
Mice
2
2013
1655
0.110
Why?
Colorectal Neoplasms
1
2010
104
0.110
Why?
Treatment Outcome
3
2015
3258
0.110
Why?
Drug Hypersensitivity
1
2008
18
0.110
Why?
Adenocarcinoma
1
2010
221
0.110
Why?
Research Design
1
2010
185
0.110
Why?
Patient Selection
1
2010
232
0.110
Why?
Chi-Square Distribution
1
2008
176
0.110
Why?
Linear Models
1
2008
256
0.100
Why?
Analysis of Variance
1
2008
364
0.100
Why?
Minimally Invasive Surgical Procedures
1
2011
260
0.100
Why?
Male
6
2017
15162
0.100
Why?
Aged
4
2017
8625
0.100
Why?
Sensitivity and Specificity
1
2008
574
0.090
Why?
Tomography, X-Ray Computed
1
2011
807
0.090
Why?
Follow-Up Studies
1
2011
1798
0.090
Why?
Risk Assessment
1
2008
697
0.090
Why?
Female
5
2017
15514
0.080
Why?
Cohort Studies
1
2008
1575
0.080
Why?
Young Adult
2
2017
1849
0.060
Why?
Clinical Trials as Topic
2
2012
365
0.060
Why?
Postoperative Complications
2
2017
953
0.050
Why?
Pain Clinics
1
2017
6
0.050
Why?
Intention to Treat Analysis
1
2017
6
0.050
Why?
Lymphatic Metastasis
1
2017
96
0.050
Why?
Lymphedema
1
2017
21
0.050
Why?
Disease-Free Survival
1
2017
213
0.050
Why?
Academic Medical Centers
1
2017
136
0.050
Why?
Palliative Care
1
2017
104
0.050
Why?
Survival Analysis
1
2017
362
0.050
Why?
Aged, 80 and over
2
2017
4397
0.050
Why?
Dose-Response Relationship, Drug
1
2017
507
0.050
Why?
Proportional Hazards Models
1
2017
321
0.050
Why?
Ultrasonography
1
2017
181
0.050
Why?
Prognosis
1
2017
864
0.040
Why?
Antigens
1
2013
30
0.040
Why?
Antigen-Presenting Cells
1
2013
18
0.040
Why?
Medical Oncology
1
2013
36
0.040
Why?
Vaccination
1
2013
29
0.040
Why?
Neoplasm Metastasis
1
2013
132
0.040
Why?
Transfection
1
2013
148
0.040
Why?
Forecasting
1
2013
121
0.040
Why?
Dendritic Cells
1
2013
61
0.040
Why?
Transcription, Genetic
1
2013
122
0.040
Why?
Skin
1
2013
125
0.040
Why?
Anxiety
1
2013
131
0.040
Why?
Disease Management
1
2013
115
0.040
Why?
Models, Immunological
1
2012
8
0.030
Why?
Peptides
1
2013
112
0.030
Why?
Drug Evaluation, Preclinical
1
2012
35
0.030
Why?
Phenotype
1
2013
321
0.030
Why?
Evidence-Based Medicine
1
2013
210
0.030
Why?
Lymphocyte Activation
1
2013
212
0.030
Why?
T-Lymphocytes
1
2013
228
0.030
Why?
Societies, Medical
1
2013
180
0.030
Why?
Mice, Inbred C57BL
1
2013
454
0.030
Why?
Stress, Psychological
1
2013
253
0.030
Why?
Inflammation
1
2013
289
0.030
Why?
Models, Animal
1
2010
147
0.030
Why?
Disease Progression
1
2013
741
0.030
Why?
United States
1
2013
2029
0.020
Why?
Bines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description